Human amniotic mesenchymal stem cells inhibit hepatocellular carcinoma in tumour‐bearing mice

Hepatocellular carcinoma (HCC) is the third leading cause of the cancer‐related death in the world. Human amniotic mesenchymal stem cells (hAMSCs) have been characterized with a pluripotency, low immunogenicity and no tumorigenicity. Especially, the immunosuppressive and anti‐inflammatory effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Quan‐Wen, Li, Jing‐Yuan, Zhang, Xiang‐Cheng, Liu, Yu, Liu, Qian‐Yu, Xiao, Ling, Zhang, Wen‐Jie, Wu, Han‐You, Deng, Ke‐Yu, Xin, Hong‐Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521292/
https://www.ncbi.nlm.nih.gov/pubmed/32798252
http://dx.doi.org/10.1111/jcmm.15668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521292/
https://www.ncbi.nlm.nih.gov/pubmed/32798252
http://dx.doi.org/10.1111/jcmm.15668

Ejemplares similares